Filing metadata

Accession number
0001104659-24-050577
Form type
Form 4
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Apr 23, 2024
Reporting period
Apr 22, 2024
Description
Insider transaction

Explore SEC Filings Hub